OPKO Health, Inc. (TLV:OPK)
Israel
· Delayed Price · Currency is ILS · Price in ILA 508.80
-2.20 (-0.43%)
Apr 28, 2025, 5:24 PM IDT
OPKO Health Revenue
In the year 2024, OPKO Health had annual revenue of $713.14M USD, down -17.41%. OPKO Health had revenue of $183.64M in the quarter ending December 31, 2024, with 0.95% growth.
Revenue
$713.14M
Revenue Growth
-17.41%
P/S Ratio
1.32
Revenue / Employee
$237.95K
Employees
2,997
Market Cap
3.43B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 920.37M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |
OPKO Health News
- 3 days ago - This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga
- 24 days ago - OPKO Health authorizes $100 million increase to share buyback program - Seeking Alpha
- 24 days ago - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewsWire
- 6 weeks ago - OPKO and Entera partner to develop obesity pill - Reuters
- 6 weeks ago - Tesla Stock Is Reaching a Breaking Point, Analyst Says. Plus, Vertical Aerospace, OPKO Health, and More. - Barron's
- 6 weeks ago - Labcorp to buy certain assets of OPKO unit BioReference Health - Seeking Alpha
- 6 weeks ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 2 months ago - Decoding OPKO Health Inc (OPK): A Strategic SWOT Insight - GuruFocus